2021
DOI: 10.1016/j.molstruc.2021.130159
|View full text |Cite
|
Sign up to set email alerts
|

Isatin-Schiff's base and chalcone hybrids as chemically apoptotic inducers and EGFR inhibitors; design, synthesis, anti-proliferative activities and in silico evaluation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
27
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 49 publications
(27 citation statements)
references
References 69 publications
0
27
0
Order By: Relevance
“…Based on the above findings, and in continuation to our work on the synthesis of new compounds with biological activities [28][29][30][31][32][33][34], we have synthesized a new series of quinolone-3-carboxamide derivatives containing a series of biologically active moites that are expected to be strongly inhibitory for several human cell lines and PIM-1 inhibitors as a result of our commitment to search for new potential anticancer agents related to heterocyclic [35][36][37][38][39][40][41][42]. | P a g e…”
Section: Figure 1: Structures For Pim-1 Inhibitors and The Newly Designed Quinoline Hybridsmentioning
confidence: 58%
See 1 more Smart Citation
“…Based on the above findings, and in continuation to our work on the synthesis of new compounds with biological activities [28][29][30][31][32][33][34], we have synthesized a new series of quinolone-3-carboxamide derivatives containing a series of biologically active moites that are expected to be strongly inhibitory for several human cell lines and PIM-1 inhibitors as a result of our commitment to search for new potential anticancer agents related to heterocyclic [35][36][37][38][39][40][41][42]. | P a g e…”
Section: Figure 1: Structures For Pim-1 Inhibitors and The Newly Designed Quinoline Hybridsmentioning
confidence: 58%
“…Doxorubicin were subjected to screening by the Swiss ADMET website (http://www.sib.swiss) interface, provoking the in-silico ADME characteristics and examining their aptitude to exhibit drug-likeliness [54][55][56][57].…”
Section: In-silico Studymentioning
confidence: 99%
“…Doxorubicin were subjected to screening by the Swiss ADMET website (http://www.sib.swiss) interface, provoking the in-silico ADME characteristics and examining their aptitude to exhibit drug-likeliness [54][55][56][57].…”
Section: In-silico Studymentioning
confidence: 99%
“…It has now been documented to be effective for cancer therapy [27] and for reduction of undesirable side effects [17] by developing a single molecule with more than one pharmacopher with different action modes. with biological activities [28][29][30][31][32][33][34], we have synthesized a new series of quinolone-3-carboxamide derivatives containing a series of biologically active moites that are expected to be strongly inhibitory for several human cell lines and PIM-1 inhibitors as a result of our commitment to search for new potential anticancer agents related to heterocyclic [35][36][37][38][39][40][41][42]. N-(4-Aminophenyl)-2-cyanoacetamide (8) [44] has two nucleophilic centers which may be to react with the aldehyde function of 1.…”
Section: Introducionmentioning
confidence: 99%
“…Many chalcones have the ability to inhibit tumour proliferation by a variety of mechanisms as inhibition of tubulin 20 , epidermal growth factor receptor (EGFR) 33 , vascular endothelial growth factor receptor-2 (VEGFR-2) 5 , 15 and mitogen-activated protein kinase (MAPK) 29 , 34 .…”
Section: Introductionmentioning
confidence: 99%